PubMed

Monitoring metabolic control in diabetic outpatients with glycosylated hemoglobin.

Boden G, Master RW, Gordon SS, Shuman CR, Owen OE.

Ann Intern Med. 1980 Mar;92(3):357-60.PMID: 7356230 [PubMed - indexed for MEDLINE]Related articles

Haemoglobin A1 in diabetes mellitus.

Bartley PC, Hambling TE.

Aust N Z J Med. 1979 Feb;9(1):49-53.PMID: 287443 [PubMed - indexed for MEDLINE]Related articles

Adjuvant therapy with tolazamide and insulin improves metabolic control in type I diabetes mellitus.

Kabadi UM.

Diabetes Care. 1985 Sep-Oct;8(5):440-6.PMID: 3902422 [PubMed - indexed for MEDLINE]Related articles

Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of sulfonylurea therapy and plasma glucose levels on hemoglobin A1c in type II diabetes mellitus.

Schultz TA, Lewis SB, Davis JL, Rost CR, Bliziotes MM.

Am J Med. 1981 Feb;70(2):373-8.PMID: 7468619 [PubMed - indexed for MEDLINE]Related articles

The relationship between blood glycosylated haemoglobin and home capillary blood glucose levels in diabetics.

Paisey RB, Macfarlane DG, Sherriff RJ, Hartog M, Slade RR, White DA.

Diabetologia. 1980 Jul;19(1):31-4.PMID: 6993265 [PubMed - indexed for MEDLINE]Related articles

Haemoglobin A1: An indicator of the metabolic control of diabetic patients.

Gonen B, Rubenstein A, Rochman H, Tanega SP, Horwitz DL.

Lancet. 1977 Oct 8;2(8041):734-7.PMID: 71541 [PubMed - indexed for MEDLINE]Related articles

Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control.

Bonora E, Calcaterra F, Lombardi S, Bonfante N, Formentini G, Bonadonna RC, Muggeo M.

Diabetes Care. 2001 Dec;24(12):2023-9.PMID: 11723077 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of chronic oral antidiabetic therapy on insulin and glucagon responses to a meal.

Tsalikian E, Dunphy TW, Bohannon NV, Lorenzi M, Gerich JE, Forsham PH, Kane JP, Karam JH.

Diabetes. 1977 Apr;26(4):314-21.PMID: 849812 [PubMed - indexed for MEDLINE]Related articles

Stability of hemoglobin AIc levels on repetitive determination in diabetic out-patients.

Dunn PJ, Cole RA, Soeldner JS, Gleason RE.

J Clin Endocrinol Metab. 1981 May;52(5):1019-22.PMID: 7228986 [PubMed - indexed for MEDLINE]Related articles

Bromocriptine: a novel approach to the treatment of type 2 diabetes.

Pijl H, Ohashi S, Matsuda M, Miyazaki Y, Mahankali A, Kumar V, Pipek R, Iozzo P, Lancaster JL, Cincotta AH, DeFronzo RA.

Diabetes Care. 2000 Aug;23(8):1154-61.PMID: 10937514 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.

Derosa G, Cicero AF, Gaddi AV, Ciccarelli L, Piccinni MN, Salvadeo S, Pricolo F, Fogari E, Ghelfi M, Ferrari I, Fogari R.

Clin Ther. 2005 Sep;27(9):1383-91.PMID: 16291411 [PubMed - indexed for MEDLINE]Related articles

The relationship between self-monitoring of blood glucose control and glycosylated haemoglobin in patients with type 2 diabetes with and without diabetic retinopathy.

Ozmen B, Boyvada S.

J Diabetes Complications. 2003 May-Jun;17(3):128-34.PMID: 12738396 [PubMed - indexed for MEDLINE]Related articles

Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.

Derosa G, Cicero AF, D'Angelo A, Gaddi A, Ciccarelli L, Piccinni MN, Salvadeo SA, Pricolo F, Ferrari I, Gravina A, Ragonesi PD.

Clin Ther. 2006 May;28(5):679-88. Erratum in: Clin Ther. 2006 Sep;28(9):1483. PMID: 16861090 [PubMed - indexed for MEDLINE]Related articles

Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

Clin Ther. 2008 Aug;30(8):1448-60. Erratum in: Clin Ther. 2008 Oct;30(10):1937. PMID: 18803987 [PubMed - indexed for MEDLINE]Related articles

Changes in glycosylated haemoglobin after poor control in insulin-dependent diabetics.

Brooks AP, Nairn IM, Baird JD.

Br Med J. 1980 Sep 13;281(6242):707-10.PMID: 7000273 [PubMed - indexed for MEDLINE]Related articlesFree article

Development of diabetic microangiopathy and diabetic control. A study in non-insulin-dependent diabetics.

Maneschi F, Cassar J, Lowy C, Kohner EM.

Diabete Metab. 1981 Sep;7(3):181-7.PMID: 7033009 [PubMed - indexed for MEDLINE]Related articles

Potentiation of hypoglycemic effect of chlorpropamide and phenfromin by halofenate.

Kudzma DJ, Friedberg SJ.

Diabetes. 1977 Apr;26(4):291-5.PMID: 321288 [PubMed - indexed for MEDLINE]Related articles

Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring.

Hay LC, Wilmshurst EG, Fulcher G.

Diabetes Technol Ther. 2003;5(1):19-26.PMID: 12725703 [PubMed - indexed for MEDLINE]Related articles